Published on September 25, 2009 at 8:27 AM
Research and Markets(http://www.researchandmarkets.com/research/03c458/nuclear_oncology) has announced the addition of the "Nuclear Oncology" training to their offering.
The Johns Hopkins University School of Medicine
Genetic alterations often indicate the risk of developing cancer and can define molecular signatures suitable for radionuclide diagnosis and therapy. Once identified, they can be targets for stable or radioactive pharmaceuticals to try to bring about complete or partial remission of the patient's disease. This program in Nuclear Oncology covers imaging, dosimetric, and therapeutic applications of radiopharmaceuticals and metabolic imaging agents, with descriptions of how these techniques are being applied in the care of patients. The integration of imaging to personalized treatment choices is also emphasized.
Target Audience
This program will have special relevance for nuclear medicine physicians, radiologists, and radiation oncologists, and will also be useful for all who treat patients with cancer.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Improve their ability to treat patients with Lymphoma
- Select appropriate therapy for a variety of tumors
- Describe particular advantages of alpha therapy
- Describe current and future directions of research
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 9.70 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
http://www.researchandmarkets.com/
761b230b-4770-45a8-a1ba-5d9a2ecca939|0|.0
Posted in: Device / Technology News
Tags: Bismuth, Bone, Brain, Cancer, Education, Leukemia, Lung Cancer, Lymphoma, Nuclear Medicine, Oncology, Pancreatic Cancer, Radioiodine, Radiology, Thyroid Cancer, Venom